Executive Summary
A global specialty generic pharmaceutical company needed Ceretec, a tightly regulated radiopharmaceutical, and spent over four months without finding a reliable source. Spring Bio Solution identified a compliant supply pathway and completed delivery within 45 days.
The Challenge
Ceretec is a radiopharmaceutical used in brain perfusion imaging and white blood cell labeling, a niche product with an extremely short shelf life, stringent regulatory requirements, and a very limited global distribution network. It’s sourcing demands not just industry contacts, but deep, real-time insights that most procurement teams simply don’t possess.
Our client, a well-established pharmaceutical company, had been searching for it independently for four to five months. Despite their industry standing and internal procurement capabilities, they hit wall after wall: unresponsive suppliers, unclear regulatory pathways, and a general scarcity of actionable sourcing knowledge for this category.
The real problem wasn’t a lack of effort; it was a lack of market intelligence.
Why It Was Difficult
Without knowing exactly where Ceretec moves, who manufactures it, and which distribution channels are reliably active, even the best procurement teams are searching in the dark.
Spring Bio Solution’s Approach
Spring Bio Solution activated its global sourcing network, built and refined over 15 years of working with Reference Listed Drugs and specialty pharmaceuticals.
Our team identified active, compliant supply channels for Ceretec that weren’t accessible through validated global supply channels identified through our specialty sourcing network.
We managed the entire sourcing process end-to-end, including regulatory documentation, import coordination, and last-mile delivery, ensuring the product arrived intact and fully compliant.
Outcome
- Ceretec sourced and delivered within 45 days of first contact
- Product integrity is maintained end-to-end
- Full regulatory compliance on import documentation
- Client’s 4 to 5 month sourcing gap resolved in a single engagement
Key Capabilities Demonstrated
- 15+ years of RLD sourcing expertise
- 400+ global distribution partners
- 45+ manufacturer relationships worldwide
Our sourcing intelligence on specialty and hard-to-source drugs, including radiopharmaceuticals, is built from decades of active market presence, not databases. When a product is difficult, rare, or tightly regulated, Spring Bio Solution can act as an edge for your sourcing strategy.
Facing a Comparator Sourcing Challenge?
Whether it’s radiopharmaceuticals, including certain non-radioactive radiopharmaceuticals, REMS (ETASU) programs, biologics, orphan drugs, enteral feeding tubes, hospital and retail-specific products, or even specialized impurities, if you’re facing roadblocks, chances are we’ve solved them before.